Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BioNTech SE

< Previous 1 2 3 Next >
News headline image
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Announces Planned Retirement of Sean Marett
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Inaugurate First African Site on December 18, 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial with mRNA-based Individualized Neoantigen Specific Immunotherapy in New Cancer Indication
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Completes Acquisition of InstaDeep
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Report Second Quarter 2023 Financial Results and Operational Update on August 7, 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
News headline image
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
From BioNTech SE
Via GlobeNewswire
Tickers BNTX
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.